At Digestive Disease Week (DDW) 2025, Virgo Surgical Video Solutions, Inc. introduced EndoML, an artificial intelligence development platform poised to reshape how AI is created and deployed in gastroenterology. Built on the company’s powerful EndoDINO foundation model, EndoML bridges the gap between research and clinical implementation, offering researchers a faster, more efficient path to innovation.
What Is EndoML?
EndoML is a purpose-built AI development platform that enables gastroenterologists and pharmaceutical researchers to build custom AI models using their proprietary datasets. Whether identifying anatomical landmarks, scoring disease severity, or segmenting polyps, EndoML aims to simplify and speed up development.
Features:
- Powered by EndoDINO: Trained on 130,000+ full-length GI endoscopy videos, EndoDINO delivers high accuracy across multiple GI applications.
- Data-Efficient Training: Achieve strong performance with less labeled data.
- Accessible Models: Researchers can reuse, share, or expand models within the platform or in external environments.
Why EndoML Matters
Virgo’s CEO Matt Schwartz emphasized the platform’s broader vision: “Our goal is to streamline and democratize AI development in gastroenterology, facilitating quicker transitions from research innovations to tangible patient care improvements.”
With built-in flexibility, EndoML serves both academic and commercial needs, providing:
- Clinical utility: Accelerated development of AI for diagnosis and treatment.
- Pharma innovation: Support for model deployment within pharma’s internal environments or via Virgo’s VirgoTrials platform.
Use Cases Already Demonstrated
Virgo has already showcased EndoML’s capabilities in action:
- Mayo Endoscopic Scoring: High accuracy at both frame- and video-level analysis.
- Integration with VirgoTrials: Seamless connection between AI models and trial data systems.
Chris Lawcock, VP of Engineering at Virgo, highlighted the practical edge: “Sponsors can train and deploy models on their own terms. EndoML is a comprehensive solution designed for today’s research demands.”
With the launch of EndoML, Virgo empowers the medical and pharmaceutical research community to move from AI idea to clinical impact faster than ever. Built on EndoDINO’s proven foundation and designed for real-world application, EndoML could mark a new chapter in AI-driven healthcare—especially for gastrointestinal research and care.
